BioSpace News Archive

Drug Development

Eli Lilly and Company Release: Type 2 Diabetes: Jardiance® (Empagliflozin) As An Add-On Therapy Significantly Reduced Blood Glucose And Body Weight In Two Newly Presented Phase 3 Trials

June 16, 2014
·
1 min read
Lone Star Bio

SpinalCyte, LLC Announces Final Animal Trials For Spinal Disc Tissue Engineering

June 16, 2014
·
1 min read
Deals

Covidien plc Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue

June 16, 2014
·
1 min read
Lone Star Bio

Apollo Endosurgery, Inc. Revitalizes the LAP-BAND® System With New “It Fits” Campaign

June 16, 2014
·
1 min read
Biotech Beach

Exostar And SAFE-BioPharma, LLC Partner To Introduce Level 2 And 3 Non-PKI Identity Credentials To Exostar’s Leading Life Sciences And Healthcare Industry Identity Hub

June 16, 2014
·
1 min read
Drug Development

Agios Pharmaceuticals Announces Orphan Drug Designation Of AG-221 For Treatment Of Acute Myelogenous Leukemia

June 16, 2014
·
1 min read
Business

Veristat, Inc. And Karyopharm Therapeutics Enter Into Preferred Provider Agreement For Oncology And Novel Therapeutic Advancement

June 16, 2014
·
1 min read
Biotech Beach

SAS Release: Pharma Improves Care By Sharing Clinical Trial Data

June 16, 2014
·
1 min read
Business

Cubist Pharmaceuticals, Inc. Selects TransPerfect Trial Interactive’s Trial Interactive Platform As Its eTMF Solution

June 16, 2014
·
1 min read
Genetown

ImmunoGen, Inc. Announces Preclinical Findings For IMGN779, A Potential Treatment For Acute Myeloid Leukemia

June 16, 2014
·
1 min read